Test Bank for Pharmacology and the Nursing Process 9th Edition Linda Lilley Shelly Collins Julie Snyder Complete Guide A+

,Chapter 1 - The Nursing Process and Drug Therapy ______________________ 3
g g g g g g g g




Chapter 2 - Pharmacologic Principles _________________________________ 7
g g g g




Chapter 3 - Lifespan Considerations _________________________________ 13
g g g g




Chapter 4 - Cultural Legal and Ethical Considerations ____________________ 19
g g g g g g g




Chapter 5 - Medication Errors Preventing and Responding ________________ 25
g g g g g g g




Chapter 6 - Patient Education and Drug Therapy ________________________ 29
g g g g g g g




Chapter 7 - Over-the-Counter Drugs and Herbal and Dietary Supplements
g g g g g g g g g




g 34 Chapter 8 - Gene Therapy and Pharmacogenomics _________________ 38
g g g g g g g




Chapter 9 - Photo Atlas of Drug Administration _________________________ 42
g g g g g g g




Chapter 10 - Analgesic Drugs _______________________________________ 50
g g g g




Chapter 11 - General and Local Anesthetics ___________________________ 57
g g g g g g




Chapter 12 - Central Nervous System Depressants and Muscle Relaxants
g g g g g g g g g




g 61 Chapter 13 - Central Nervous System Stimulants and Related Drugs ____ 66
g g g g g g g g g g




Chapter 14 - Antiepileptic Drugs _____________________________________ 70
g g g g




Chapter 15 - Anti-Parkinson Drugs ___________________________________ 75
g g g g




Chapter 16 - Psychotherapeutic Drugs ________________________________ 80
g g g g




Chapter 17 - Substance Use Disorder ________________________________ 87
g g g g g




Chapter 18 - Adrenergic Drugs _______________________________________ 92
g g g g




Chapter 19 - Adrenergic-Blocking Drugs ______________________________ 97
g g g g




Chapter 20 - Cholinergic Drugs______________________________________ 102
g g g g




Chapter 21 - Cholinergic-Blocking Drugs ______________________________ 107
g g g g




Chapter 22 - Antihypertensive Drugs _________________________________ 112
g g g g




Chapter 23 - Antianginal Drugs ______________________________________ 118
g g g g




Chapter 24 - Heart Failure Drugs ____________________________________ 124
g g g g g




Chapter 25 - Antidysrhythmic Drugs __________________________________ 129
g g g g




Chapter 26 - Coagulation Modifier Drugs ______________________________ 134
g g g g g




Chapter 27 - Antilipemic Drugs ______________________________________ 140
g g g g




Chapter 28 - Diuretic Drugs ________________________________________ 145
g g g g




Chapter 29 - Fluids and Electrolytes __________________________________ 151
g g g g g




Chapter 30 - Pituitary Drugs ________________________________________ 157
g g g g

,Chapter 31 - Thyroid and Antithyroid Drugs ____________________________ 161
g g g g g g




Chapter 32 - Antidiabetic Drugs _____________________________________ 166
g g g g




Chapter 33 - Adrenal Drugs ________________________________________ 174
g g g g




Chapter 34 - Women’s Health Drugs _________________________________ 178
g g g g g




Chapter 35 - Men’s Health Drugs ____________________________________ 185
g g g g g




Chapter 36 - Antihistamines Decongestants Antitussives and Expectorants
g g g g g g g




g 189 Chapter 37 - Respiratory Drugs _________________________________ 194
g g g g g




Chapter 38 - Antibiotics Part 1 ______________________________________ 199
g g g g g




Chapter 39 - Antibiotics Part 2 ______________________________________ 206
g g g g g




Chapter 40 - Antiviral Drugs ________________________________________ 211
g g g g




Chapter 41 - Antitubercular Drugs ___________________________________ 216
g g g g




Chapter 42 - Antifungal Drugs ______________________________________ 221
g g g g




Chapter 43 - Antimalarial Antiprotozoal and Anthelmintic Drugs ____________ 226
g g g g g g g




Chapter 44 - Anti-inflammatory and Antigout Drugs ______________________ 231
g g g g g g




Chapter 45 - Antineoplastic Drugs Part 1 Cancer Overview and Cell Cycle
g g g g g g g g g g g




g 236 Chapter 46 - Antineoplastic Drugs Part 2 Cell Cycle Nonspecific and Misc.
g g g g g g g g g g g g




Drugs _________________________________________________________ 242
Chapter 47 - Biologic Response–Modifying and Antirheumatic Drugs ________ 247
g g g g g g g




Chapter 48 - Immunosuppressant Drugs ______________________________ 252
g g g g




Chapter 49 - Immunizing Drugs _____________________________________ 257
g g g g




Chapter 50 - Acid-Controlling Drugs __________________________________ 262
g g g g




Chapter 51 - Bowel Disorder Drugs __________________________________ 268
g g g g g




Chapter 52 - Antiemetic and Antinausea Drugs _________________________ 275
g g g g g g




Chapter 53 - Vitamins and Minerals __________________________________ 280
g g g g g




Chapter 54 - Anemia Drugs ________________________________________ 286
g g g g




Chapter 55 - Nutritional Supplements _________________________________ 292
g g g g




Chapter 56 - Drugs _______________________________________________ 296
g g g




Chapter 57 - Ophthalmic Drugs _____________________________________ 302
g g g g




Chapter 58 - Otic Drugs ___________________________________________ 307
g g g g

, 3

Chapter 01: The Nursing Process and Drug Therapy
g g g g g g g


Lilley: Pharmacology and the Nursing Process, 9th Edition
g g g g g g g g




MULTIPLE CHOICE g




1. The nurse is developing a human needs statement for a patient who has a new diagnosis of
g g g g g g g g g g g g g g g g


heart failure. Identification of human needs statements occur with which of these
g g g g g g g g g g g g


activities?
g


a. Collection of patient data g g g


b. Administering interventions g


c. Deciding on patient outcomes g g g


d. Documenting the patient‘s behavior g g g




ANS: A g


Identification of human needs occurs with the collection of patient data. g g g g g g g g g g




DIF: Cognitive Level: Understanding (Comprehension) g g g


TOP: Nursing Process: Human Needs Statement
g g g g g g


MSC: NCLEX: Safe and Effective Care Environment: Management of Care
g g g g g g g g g




2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was
g g g g g g g g g g g g g g


busy and gave the medication 2 hours after the scheduled dose was due. What type of
g g g g g g g g g g g g g g g g


problem does this represent?
g g g g


a. ―Right time‖ g


b. ―Right dose‖ g


c. ―Right route‖ g


d. ―Right medication‖ g




ANS: A g


―Right time‖ is correct because the medication was given more than 30 minutes after the
g g g g g g g g g g g g g g


scheduled dose was due. ―Dose‖ is incorrect because the dose is not related to the time the
g g g g g g g g g g g g g g g g g


medication administration is scheduled. ―Route‖ is incorrect because the route is not
g g g g g g g g g g g g


affected. ―Medication‖ is incorrect because the medication ordered will not change.
g g g g g g g g g g g




DIF: Cognitive Level: Applying (Application) g g g


TOP: Nursing Process: Implementation
g g g g


MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
g g g g g g g g g g




3. The nurse has been monitoring the patient‘s progress on a new drug regimen since the first
g g g g g g g g g g g g g g g


dose and documenting the patient‘s therapeutic response to the medication. Which phase
g g g g g g g g g g g g


of the nursing process do these actions illustrate?
g g g g g g g g


a. Human needs statement g g


b. Planning
c. Implementation
d. Evaluation
ANS: D g


Monitoring the patient‘s progress, including the patient‘s response to the medication, is
g g g g g g g g g g g


part of the evaluation phase. Planning, implementation, and human needs statement are not
g g g g g g g g g g g g g


illustrated by this example.
g g g g




Chapter 1 - The Nursing Process and Drug Therapy
g g g g g g g g 3